Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ali Salehi Farid, Pharm.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kianfar N, Dasdar S, Salehi Farid A, Balighi K, Mahmoudi H, Daneshpazhooh M. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association? Front Med (Lausanne). 2022; 9:957169. PMID: 35928293; PMCID: PMC9344059.
  2. Nili A, Karimi S, Salehi Farid A, Molhem Azar P, Farimani Z, Shahbazian H, Balighi K, Tavakolpour S, Mahmoudi H, Daneshpazhooh M. Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study. Oral Dis. 2022 May 04. PMID: 35506253.
    Citations:    Fields:    
  3. Nili A, Salehi Farid A, Asgari M, Tavakolpour S, Mahmoudi H, Daneshpazhooh M. Current status and prospects for the diagnosis of pemphigus vulgaris. Expert Rev Clin Immunol. 2021 08; 17(8):819-834. PMID: 34162306.
    Citations: 3     Fields:    Translation:Humans
  4. Daneshpazhooh M, Tavakolpour S, Salehi Farid A, Ebadi M, Nili A, Rashidian M, Mahmoudi H. Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. Int J Dermatol. 2022 Jan; 61(1):e14-e17. PMID: 34156705.
    Citations: 1     Fields:    Translation:Humans
  5. Mahmoudi H, Nili A, Salehi Farid A, Tavakolpour S, Daneshpazhooh M. Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption. Br J Dermatol. 2021 07; 185(1):e2. PMID: 33822366.
    Citations: 1     Fields:    Translation:Humans
  6. Fallahi M, Hallaji Z, Tavakolpour S, Niknam S, Salehi Farid A, Nili A, Teimourpour A, Daneshpazhooh M, Rahmati J, Haddady Abianeh S, Mahmoudi H. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial. J Cosmet Dermatol. 2021 Aug; 20(8):2498-2506. PMID: 33251650.
    Citations: 2     Fields:    Translation:Humans
  7. Tavakolpour S, Mahmoudi H, Karami F, Elikaei Behjati S, Balighi K, Abbasi M, Salehi Farid A, Masoudi J, Balali M, Daneshpazhooh M, Modarressi MH. Investigating expression pattern of eight immune-related genes in pemphigus patients compared with the healthy controls and after rituximab therapy: Potential roles of CTLA4 and FCGR3A genes expression in outcomes of rituximab therapy. Dermatol Ther. 2020 11; 33(6):e14380. PMID: 33090639.
    Citations: 1     Fields:    Translation:Humans
  8. Nili A, Mahmoudi H, Heidari N, Tavakolpour S, Salehi Farid A, Balighi K, Daneshpazhooh M. Rituximab monotherapy in mild pemphigus. J Dermatolog Treat. 2022 05; 33(3):1784-1786. PMID: 33040641.
    Citations:    Fields:    Translation:Humans
  9. Salehi Farid A, Niknam S, Gholami K, Tavakolpour S, Teimourpour A, Daneshpazhooh M, Nili A, Azizpour A, Nasimi M, Mahmoudi H. Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial. J Dermatolog Treat. 2022 May; 33(3):1376-1382. PMID: 32875946.
    Citations:    Fields:    Translation:Humans
  10. Mahmoudi H, Tavakolpour S, Nili A, Salehi Farid A, Daneshpazhooh M, Rashidian M. Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab. Dermatol Ther. 2020 11; 33(6):e14188. PMID: 32794333; PMCID: PMC7435548.
    Citations: 2     Fields:    Translation:HumansCells
  11. Mahmoudi H, Rostami A, Tavakolpour S, Nili A, Teimourpour A, Salehi Farid A, Abedini R, Amini M, Daneshpazhooh M. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial. J Dermatolog Treat. 2022 Feb; 33(1):284-290. PMID: 32238014.
    Citations: 5     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Salehi Farid's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (30)
Co-Authors (2)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.